Human chorionic gonadotropin β subunit affects the expression of apoptosis-regulating factors in ovarian cancer

Oncology Reports

Volumn 35, Issue 1, 2016, Pages 538-545

  Szczerba, Anna ^a   ͆liwa, Aleksandra ^a   Kubiczak, Marta ^a   Nowak Markwitz, Ewa ^a   Jankowska, Anna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Apoptosis; BAX; BCL2; BIRC5; Human chorionic gonadotropin; LHCGR; Ovarian cancer

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; HORMONE RECEPTOR; LUTEINIZING HORMONE CHORIOGONADOTROPIN RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; UNCLASSIFIED DRUG; BAX PROTEIN, HUMAN; BCL2 PROTEIN, HUMAN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN;

APOPTOSIS; ARTICLE; BAX GENE; BCL2 GENE; BIRC5 GENE; CANCER STAGING; CGB5 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONE ACTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; OVARIAN CANCER CELL LINE; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84954056196     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4386     Document Type: Article

References (29)

1. Pierce JG and Parsons TF: Glycoprotein hormones: Structure and function. Annu Rev Biochem 50: 465-495, 1981.
2. Cole LA: hCG, five independent molecules. Clin Chim Acta 413: 48-65, 2012.
3. Iles RK and Butler SA: Gonadotropins and gonadotropin receptors - evolutional genetics, signalling mechanisms, extra gonadal function and roles in oncogenesis. Mol Cell Endocrinol 329: 1-2, 2010.
4. Iles RK, Delves PJ and Butler SA: Does hCG or hCGβ play a role in cancer cell biology? Mol Cell Endocrinol 329: 62-70, 2010.
5. Tsampalas M, Gridelet V, Berndt S, Foidart JM, Geenen V and Perrier d'Hauterive S: Human chorionic gonadotropin: A hormone with immunological and angiogenic properties. J Reprod Immunol 85: 93-98, 2010.
6. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Münstedt K, Rao CV, Lang U and Preissner KT: Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 87: 5290-5296, 2002.
7. Burczynska BB, Kobrouly L, Butler SA, Naase M and Iles RK: Novel insights into the expression of CGB1 and 2 genes by epithelial cancer cell lines secreting ectopic free hCGβ. Anticancer Res 34: 2239-2248, 2014.
8. Lee CL, Chiu PC, Hautala L, Salo T, Yeung WS, Stenman UH and Koistinen H: Human chorionic gonadotropin and its free β-subunit stimulate trophoblast invasion independent of LH/hCG receptor. Mol Cell Endocrinol 375: 43-52, 2013.
9. Butler SA and Iles RK: The free monomeric beta subunit of human chorionic gonadotrophin (hCG beta) and the recently identified homodimeric beta-beta subunit (hCG beta beta) both have autocrine growth effects. Tumour Biol 25: 18-23, 2004.
10. Prast J, Saleh L, Husslein H, Sonderegger S, Helmer H and Knöfler M: Human chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase and AKT signaling. Endocrinology 149: 979-987, 2008.
11. Hamada AL, Nakabayashi K, Sato A, Kiyoshi K, Takamatsu Y, Laoag-Fernandez JB, Ohara N and Maruo T: Transfection of antisense chorionic gonadotropin β gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. J Clin Endocrinol Metab 90: 4873-4879, 2005.
12. Jankowska A, Gunderson SI, Andrusiewicz M, Burczynska B, Szczerba A, Jarmolowski A, Nowak-Markwitz E and Warchol JB: Reduction of human chorionic gonadotropin beta subunit expression by modified u1 snRNA caused apoptosis in cervical cancer cells. Mol Cancer 7: 26-31, 2008.
13. Guo X, Liu G, Schauer IG, Yang G, Mercado-Uribe I, Yang F, Zhang S, He Y and Liu J: Overexpression of the β subunit of human chorionic gonadotropin promotes the transformation of human ovarian epithelial cells and ovarian tumorigenesis. Am J Pathol 179: 1385-1393, 2011.
14. Li D, Wen X, Ghali L, Al-Shalabi FM, Docherty SM, Purkis P and Iles RK: hCG beta expression by cervical squamous carcinoma - in vivo histological association with tumour invasion and apoptosis. Histopathology 53: 147-155, 2008.
15. Mandai M, Konishi I, Kuroda H and Fujii S: LH/hCG action and development of ovarian cancer - a short review on biological and clinical/epidemiological aspects. Mol Cell Endocrinol 269: 61-64, 2007.
16. Głodek A and Jankowska A: CGB activates ERK and AKT kinases in cancer cells via LHCGR-independent mechanism. Tumour Biol 35: 5467-5479, 2014.
17. Hotakainen K, Lintula S, Jarvinen R, Paju A, Stenman J, Rintala E and Stenman UH: Overexpression of human chorionic gonadotropin beta genes 3, 5 and 8 in tumor tissue and urinary cells of bladder cancer patients. Tumour Biol 28: 52-56, 2007.
18. Iles RK: Ectopic hCGbeta expression by epithelial cancer: Malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Mol Cell Endocrinol 260-262: 264-270, 2007.
19. Philchenkov A: Caspases: Potential targets for regulating cell death. J Cell Mol Med 8: 432-444, 2004.
20. Kurman RJ: Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann oncol 24 (Suppl 10): x16-21, 2013.
21. Kubiczak M, Walkowiak GP, Nowak-Markwitz E and Jankowska A: Human chorionic gonadotropin beta subunit genes CGB1 and CGB2 are transcriptionally active in ovarian cancer. Int J Mol Sci 14: 12650-12660, 2013.
22. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
23. Yin C, Knudson CM, Korsmeyer SJ and van Dyke T: Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637-640, 1997.
24. Sugino N, Suzuki T, Kashida S, Karube A, Takiguchi S and Kato H: Expression of Bcl-2 and Bax in the human corpus luteum during the menstrual cycle and in early pregnancy: Regulation by human chorionic gonadotropin. J Clin Endocrinol Metab 85: 4379-4386, 2000.
25. Basu A and Haldar S: The relationship between Bci2, Bax and p53: Consequences for cell cycle progression and cell death. Mol Hum Reprod 4: 1099-1109, 1998.
26. Yoon O and Roh J: Downregulation of KLF4 and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer. Oncol Lett 4: 1033-1036, 2012.
27. Waligórska-Stachura J, Jankowska A, Was̈ko R, Liebert W, Biczysko M, Czarnywojtek A, Baszko-Błaszyk D, Shimek V and Ruchała M: Survivin - prognostic tumor biomarker in human neoplasms - review. Ginekol Pol 83: 537-540, 2012.
28. Kumazawa Y, Kawamura K, Sato T, Sato N, Konishi Y, Shimizu Y, Fukuda J, Kodama H and Tanaka T: HCG up-regulates survivin mRNA in human granulosa cells. Mol Hum Reprod 11: 161-166, 2005.
29. Hoffman YM, Peegel H, Sprock MJ, Zhang QY and Menon KM: Evidence that human chorionic gonadotropin/luteinizing hormone receptor down-regulation involves decreased levels of receptor messenger ribonucleic acid. Endocrinology 128: 388-393, 1991.